Talphera (TLPH) Treasury Shares (2012 - 2026)
Talphera's (TLPH) quarterly Treasury Shares came in at $469065.0 in Q1 2026, up 227.96% year-on-year from $143026.0 in Q1 2025, and up 71.7% quarter-over-quarter from $273195.0 in Q4 2025.
Talphera (TLPH) Treasury Shares (2012 - 2026) Analysis & Trends
Talphera's Treasury Shares history runs 10 years deep, the most recent figure standing at $469065.0 for Q1 2026.
- On a quarterly basis, Treasury Shares rose 227.96% year-over-year to $469065.0 in Q1 2026; TTM through Mar 2026 was $469065.0, a 227.96% increase from a year earlier, with the FY2025 full-year figure at $273195.0, up 28.31% from the prior year.
- Treasury Shares rose to $469065.0 in Q1 2026 per TLPH's latest filing, from $273195.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $2.0 million in Q1 2022 and bottomed at $82778.0 in Q4 2022.
- The 5-year median for Treasury Shares is $212923.0 (2024), against an average of $376166.8.
- Across the five-year window, Treasury Shares sank 95.49% in 2023 and soared 227.96% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $82778.0 in 2022, then climbed by 4.17% to $86232.0 in 2023, then soared by 146.92% to $212923.0 in 2024, then gained by 28.31% to $273195.0 in 2025, then jumped by 71.7% to $469065.0 in 2026.
- Per Business Quant, the three latest TLPH Treasury Shares figures stand at $469065.0 (Q1 2026), $273195.0 (Q4 2025), and $241196.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 469,065.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 469,065.00 |
| Mar 31, 2026 | 469,065.00 |
| Dec 31, 2025 | 273,195.00 |
| Dec 31, 2025 | 273,195.00 |
| Sep 30, 2025 | 241,196.00 |
| Sep 30, 2025 | 241,196.00 |
| Jun 30, 2025 | 241,196.00 |
| Jun 30, 2025 | 241,196.00 |
| Mar 31, 2025 | 143,026.00 |
| Mar 31, 2025 | 143,026.00 |
| Dec 31, 2024 | 212,923.00 |
| Dec 31, 2024 | 212,923.00 |
| Sep 30, 2024 | 216,246.00 |
| Sep 30, 2024 | 216,246.00 |
| Jun 30, 2024 | 223,240.00 |
| Jun 30, 2024 | 223,240.00 |
| Mar 31, 2024 | 178,663.00 |
| Mar 31, 2024 | 178,663.00 |
| Dec 31, 2023 | 86,232.00 |
| Dec 31, 2023 | 86,232.00 |